Repertoire Immune Medicines
MA - CambridgeBiotechnology
Focus: Repertoire Immune Medicines is a cell and peptide-based therapy biotech focused on oncology, based in Cambridge, MA. The company is in early-stage development with a focus on immunotherapies for solid tumors.
Profile data last refreshed 17h ago · AI intelligence enriched 2w ago
Open Jobs
2+2 this month
Stable — net +2 jobs in 30d
2 added, 0 removed. Backfill posture.
Should You Work at Repertoire Immune Medicines?
AI assessmentBest suited for early-stage scientists willing to accept high technical and financial risk for equity upside and platform ownership in emerging immunotherapy space.
Why Work Here
- Early-stage immunotherapy platform with proprietary cell and peptide modalities targeting large oncology market
- Opportunity to shape company culture and scientific direction from ground floor in high-growth Cambridge biotech hub
Data completeness
2/9 — Limited
Company HealthSolid
Pipeline
Early-stage
4 total
LOE Risk
Protected
No near-term cliffs
Hiring
Stable
Automated analysis based on publicly available data (FDA, SEC, ClinicalTrials.gov). May be incomplete or delayed. This score does not reflect insider knowledge and should not be used as the sole basis for investment or employment decisions.
Pipeline & Clinical Trials
Tumor Profiling
Head and Neck CancerClinical Trials (1)
NCT05061940This SCR-103 Protocol Will Permit Sites to Proactively Assess TAA, HLA and HPV-16 Status in Patients With Selected Solid Tumors to Determine Suitability for Repertoire Immune Medicines Treatment Protocols.
N/AHelp build intelligence for Repertoire Immune Medicines
No one has shared interview or compensation data for this company yet. You'll earn 7 days of Pro access.
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.